Thread: Dow Jones Today Rallies, Goldman Up, Boeing Down; Amarin Scores A Breakout

That old link actually re-links to the latest from Amarin update at IBD - down 67% in AH. Those that haven't followed AMRN, it was a real growth high flyer in late 2018-2019 with multiple huge up days.

Meanwhile, Amarin (AMRN) crashed 66%, near 4.60, after the company reportedly lost a key patent battle. A Nevada judge reportedly ruled generic drugmakers can knock off the biotech company's high triglycerides treatment, Vascepa.